![](/img/cover-not-exists.png)
ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer
David Raben, Barbara A. Helfrich, Dan Chan, Gary Johnson, Paul A. Bunn JrVolume:
29
Year:
2002
Language:
english
Pages:
10
DOI:
10.1053/sonc.2002.31521
File:
PDF, 107 KB
english, 2002